We report the cloning and sequencing of the putative structural region of the hepatitis C virus (HCV) genome (2229 nucleotides) from an isolate derived from a British case of chronic sporadic non-A, non-B hepatitis. The overall sequence shows a higher similarity with one type of HCV, HCV1 (92% L than with HCV2 (80%), is very highly conserved at the 5' end (99 %) preceding the long open reading frame, is well conserved also in the putative core region (90 to 97 %
We report the cloning and sequencing of the putative structural region of the hepatitis C virus (HCV) genome (2229 nucleotides) from an isolate derived from a British case of chronic sporadic non-A, non-B hepatitis. The overall sequence shows a higher similarity with one type of HCV, HCV1 (92% L than with HCV2 (80%), is very highly conserved at the 5' end (99 %) preceding the long open reading frame, is well conserved also in the putative core region (90 to 97 %), but shows marked variation in the putative envelope region, particularly in the envelope 2/non-structural 1 region (70%). The putative core gene was cloned in pJ3f~ under the early simian virus 40 promoter and expressed in human hepatoma cells. A predominantly cytoplasmic 22K polypeptide was expressed which was antigenically reactive with serum from chronically infected HCV patients.
Hepatitis C virus (HCV) is a recently described agent responsible for more than 90~ of cases of posttransfusion non-A, non-B hepatitis (Robinson, 1982) . The virus genome was first cloned by workers at Chiron Corporation from a bacteriophage 2 expression library and an antibody assay was subsequently developed which was capable of detecting infection in a large proportion of cases of post-transfusion hepatitis Kuo et al., 1989) . From three complete sequences published recently (Kato et al., 1990; Takamizawa et al., 1991 ; Choo et al., 1991) it is apparent that the ssRNA genome is of positive polarity, approximately 9400 nucleotides (nt) in length and contains an open reading frame (ORF) which runs throughout most of the genome. Similarities with flaviviruses and pestiviruses and the hydrophilicity/hydrophobicity profile of the encoded protein suggest that the structural genes are clustered near the 5' end and followed by the nonstructural genes. Untranslated flanking regions have been described at both the 5' and 3' termini, the former being highly conserved in the sequences published so far and thought to contain regulatory elements required for viral replication .
In this study we report the sequencing of the 5'-terminal region and putative structural domain from a single isolate derived from a British case of chronic sporadic hepatitis. Part of the structural region comprising the first 619 nt [206 amino acids (aa)] and corresponding to the putative core was cloned in a 0001-0737 © 1992 SGM eukaryotic vector and expressed in transfected human hepatoma cells (Huh-7).
Serum samples from chronic non-A, non-B hepatitis cases diagnosed by clinical criteria and serological tests to exclude known forms of viral hepatitis were assayed for the presence of antibodies to the C-100 protein of the non-structural region of HCV with a commercial ELISA kit (Ortho Diagnostics) and to the p22 protein of the structural region of HCV with a recently developed assay (Chiba et al., 1991) .
RNA was extracted from serum according to the method of Garson et al. (1990) . cDNA was synthesized from four different regions of the HCV genome by using specific synthetic primers 740, 25, 476 and 15, covering the non-coding and most of the putative structural region (Fig. 1) . The primers were selected from conserved regions of the published HCV sequences, cDNA was amplified by nested polymerase chain reaction (PCR) essentially as described by Garson et al. (1990) , using annealing temperatures selected on the basis of the G + C composition of the primers. Four overlapping regions amplified were designated 5T1 (360 bp), 5T2 (619 bp), 5T3 (996 bp) and 5T4 (469 bp) (Fig. 1) ( Maniatis et al., 1982) . Three independent clones for each fragment were sequenced by the dideoxynucleotide chain termination method using a commercial sequencing kit (Pharmacia). A computer search for N-linked glycosylation sites and host-viral protease cleavage sites was carried out.
In order to express the 5' end of the coding region in eukaryotic cells, DNA fragment 5T2 (nt 310 to 928/aa 206) starting with the first ATG of the long ORF was cloned in a eukaryotic expression vector (pJ3~) (Fig. 1) . Huh-7 cells were transfected with recombinant plasmid DNA using the conventional calcium phosphate coprecipitation method. Following transient expression (48 h) cells were immunostained using serum from a chronic non-A, non-B hepatitis patient as the first layer and fluorescein isothiocyanate-labelled rabbit antihuman Ig as the second layer. For Western blot analysis, cells 48 h * Boundaries of structural genes as suggested by Takamizawa et al. (1991) .
post-transfection were lysed by sonication and the lysate proteins separated by SDS-PAGE, transferred to a nitrocellulose filter, incubated with serum from a chronic hepatitis C patient, and finally stained with Protein Agold and enhanced with silver.
Sixteen sera from chronic non-A, non-B patients were screened by PCR for HCV-related viraemia, and one (T.C.) showing consistently high virus levels was selected for further studies.
The strategy adopted to clone and sequence the genome from this viral isolate is depicted in Fig. 1 . The primers were selected to generate terminally overlapping amplified sequences to confirm the primer sequences and to introduce a common restriction site to facilitate stepwise genome building. The sequence displayed in Fig. 2 corresponds to 2229 nt from the 5' end and shows variation of 1.6% between individual clones. The sequence shows a high degree of overall similarity (80.1 to 92.0~) (Table 1) with the four published sequences (Kato et al., 1990; Takamizawa et al., 1991 ; Choo et al., 1991 ; Okamoto et al., 1990) , which clearly demonstrates the identity between this agent of chronic sporadic hepatitis and post-transfusion HCV.
The sequence contains three ORFs of which two are located within the 5' end and a third starts at nt 310 and remains open at position 2229. The 5' flanking region preceding the long ORF consists of 309 nt and shows a high degree of similarity with published sequences (98-7 to 99.5 ~o) thus confirming a previous report stating that it is highly conserved (Okamoto et al., 1990 
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TT TGCCGGC GTCGATGCGAACAC C TAC GTCACCGGG~ TGCCGC T~u~GGGCGCATC TACAT T CGC TGGAC TG T TCGC T C C GG~ TCCAGGCAGAATA TC CAC.C TGAT CAACACCAAT 1560 378 (Fig. 3) shows a clear hydrophilic region near the 5' end followed by a region of marked hydrophobicity between aa 169 and aa 187 and another peak of marked hydrophobicity between aa 369 and aa 381 (Fig. 3) . The highly hydrophilic region at the 5r , , , 5' end of the long ORF contains over 20 ~ basic amino acids, arginine and lysine (Fig. 2) , suggesting a possible interaction between this part of the protein and the viral genome. The putative core gene sequence is 573 nt (310 to 882), encoding 191 aa (Fig. 2) , terminating at a putative signalase site at residues 191/192 (Takamizawa et al., 1991), 3' to a strongly hydrophobic region (Fig.3) . It is well preserved amongst all sequences reported so far, with the U.K. isolate showing a high degree of similarity with those of Choo et al. (1991) and Okamoto et al. (1990) , 96.9~ and 97-2~ respectively, less similarity with those of Takamizawa et al. (1991) and Kato et al. (1990) , 90.6~o and 90.1 ~ respectively, and 89.5~ with an additional partial sequence (Takeuchi et al., 1990) (Table  1 ). The conservation of this region is also very marked at the amino acid level, ranging from 97.4~ Okamoto et al., 1990; Kato et al., 1990) to 96-9~o (Takamizawa et al., 1991 ; Takeuchi et al., 1990) (Table  1) . The next gene, tentatively identified as encoding the viral envelope protein by analogy with Pestiviridae and Flaviviridae, again shows significantly higher similarities with the corresponding region of HCV 1, 91-4 ~o and 89-9~o (Okamoto et al., 1990) , than with HCV2, 74.2~ (Kato et al., 1990) and 73.2~ (Takamizawa et al., 1991) (Table 1) . As seen in the case of the envelope protein of flaviviruses, this sequence is strongly hydrophobic and contains a variety of potential N-linked glycosylation sites, seven for HCV2 and six for both our isolate and HCV1 sequences. Lastly, the presence of seven cysteine residues in this polypeptide (Fig. 2) , and their conservation in the same positions in all other sequences, suggests that they play an important role in the folding of the molecule through intramolecular disulphide bridges.
Lastly we analysed the NS1/Env2 region which was sequenced up to nt 2229 and corresponds to 251 aa. Sequence identities in this region are down to about 70~o with HCV2 (Kato et al., 1990; Takamizawa et al., 1991) and between 80 and 86~ with HCV1 Okamoto et al., 1990) . When dot matrix analysis was performed on the aa sequence of the U.K. isolate with either HCV l or HCV2, three hypervariable regions were evident (data not shown) in Envl and Env2/NS1 which are mapped in Fig. 3 . Hypervariable regions 1 and 3 of the U.K. isolate are more closely related to HCV 1 than to HCV2 whereas the hypervariable region 2 shows significant diversity from both HCV1 and HCV2. Similar hypervariable regions are found in both flaviviruses and pestiviruses a) The possible biological significance of these highly mutated regions of the genome is presently under investigation.
The second part of this study involved the expression in eukaryotic cells of the putative core region, consisting of the N-terminal 619 nt with a coding potential for 206 aa and a 22.5K protein. The cells showed strong cytoplasmic expression of antigenic material which could be stained with human serum derived from a patient with high titres of anti-P22, an antibody against a 22K HCV 'core' protein expressed in yeast. The pattern of distribution of the antigenic material was not cytosolic but predominantly in clumps, which in a number of cells were perinuclear (Fig. 4a, b) . Nuclear staining was observed only 7 to 9 days after transfection in about 30% of the cells and in this instance exclusively confined to the nucleoli (Fig. 4c) , a finding which may reflect the breakdown in the cytoplasm of the truncated viral protein followed by migration to the nucleus. Alternatively one could speculate that excessive production of a highly positive charged core protein, its breakdown, nuclear migration, and nucleolar accumulation with possible interaction with ribosomal rDNA may be relevant to the putative c.p.e, of the virus.
Finally, Western blot analysis of the product expressed in the Huh-7 transfected cells revealed a single 22K molecular species (Fig. 4d) in agreement with a corerelated polypeptide expressed in COS1 cells transfected with cDNA to the whole putative structural region (Harada et al., 1991) and a 22K polypeptide generated after in vitro processing of the expressed 970 N-terminal residues (Hijikata et al., 1991 b) . Since the predicted size for the expressed sequence is 22.5K it appears that no further modification (glycosylation or phosphorylation) of the expressed product has occurred in line with the absence of potential N-glycosylation sites in the transfected viral sequence.
Further studies involving larger segments of the structural region of HCV RNA to elucidate further the processing of HCV structural proteins are currently under way.
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